FOR IMMEDIATE RELEASE
PHILADELPHIA, USA – June 11, 2026 — The Drug Information Association (DIA) Global Annual Meeting, DIA 2026, is set to open its doors this Sunday, June 14, in Philadelphia, PA. This highly anticipated event will convene over 4,000 life sciences professionals from more than 50 countries at the Pennsylvania Convention Center, marking the latest chapter in the industry's largest and longest-running gathering dedicated to advancing global health. Building on over 60 years of scientific rigor and cross-sector collaboration, DIA 2026 is poised to be a critical nexus for tackling healthcare's most pressing challenges and accelerating solutions.
Uniting Global Leaders for Collaborative Advancement
From June 14–18, DIA 2026 will serve as a unique neutral ground, bringing together experts from industry, regulatory agencies, academia, and patient advocacy. This diverse assembly is crucial for fostering the cooperative efforts needed to drive innovation in drug development. Attendees will gain unparalleled insights into the full spectrum of the therapeutic lifecycle, from early discovery to post-market surveillance, encompassing vital areas such as regulatory affairs, clinical operations, medical affairs, quality, and safety. The meeting will feature daily plenary sessions with visionary leaders, patient advocates, and changemakers, including a keynote address from Dr. David Fajgenbaum, promising to inspire and inform.
Showcasing Cutting-Edge Innovation and Strategic Insights
The reimagined exhibit hall, "The Exchange," is gearing up to be a dynamic hub of innovation, featuring innovation theaters, content hubs, and interactive demonstrations. Key exhibit sectors will highlight the transformative roles of Therapeutic Lifecycle & Regulatory Affairs, Clinical Development & Innovation, and Data, Technology & AI in Life Sciences. Attendees will have the opportunity to explore advancements in personalized medicine, combination products, digital health, and AI-driven discovery. The LIFT Series, a dedicated program for emerging biotech startups, will host a "Whale Tank" pitch competition, offering a glimpse into the next generation of biotech and clintech innovation. Furthermore, new Therapeutic Area Pathways will provide deep-dive sessions on critical topics like obesity and oncology, alongside regulatory town halls with major global health authorities such as the FDA, MHRA, PMDA, and Health Canada.
A Premier Platform for Professional Growth and Networking
DIA 2026 offers an invaluable forum for professional development and strategic networking. Life sciences professionals, including Regulatory Affairs Directors, VPs of Clinical Operations, Medical Affairs Managers, and biotech startup founders, will find extensive opportunities to enhance their skills and knowledge. Intensive short courses and interactive problem-solving sessions will provide practical learning experiences, while "DIA Celebrate" promises a new networking experience designed to foster connections and collaborations. Exhibitors will leverage this powerful platform to showcase products and services to over 4,000 decision-makers, facilitating lead generation and direct engagement with key stakeholders. Professional buyers, in turn, will gain actionable insights to build strategic clarity and accelerate therapeutic development. To explore the full program and register for this essential event, please visit the official website: https://www.diaglobal.org/en/flagship/dia-2026.
###
About Drug Information Association Annual Meeting - DIA
The Drug Information Association (DIA) Global Annual Meeting is the life sciences industry's largest and longest-running event, with a rich history spanning over 60 years. Organized by DIA, a global non-profit founded in 1964, the meeting consistently serves as a pivotal event for mobilizing life science professionals from across all areas of expertise. It provides a neutral platform for diverse stakeholders to collaborate, advance science, policy, and patient outcomes, and drive healthcare innovation, consistently attracting participation from top pharmaceutical, clinical research, biotech, and medical device companies worldwide.
Media Contact
Contact Name: Media Relations
Company: Drug Information Association Annual Meeting - DIA Press Office
Email: [email protected]